Floatz logo

Therapeutic Asset Ratings

1,553 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lactobacillus Rhamnosus Gg
Urinary Tract Infection
Medstar Health Research InstituteEarly P1C (39)
LECANEMAB
Alzheimer Disease Type 1
Ali RezaiEarly P1C (39)
LENVATINIB
High Risk of Recurrence
Chang Gung Memorial HospitalEarly P1C (39)
Letrozole
Insulin Sensitivity/Resistance
Cairo UniversityEarly P1C (39)
Letrozole
Osteoarthritis (OA) of the Knee
The University of Hong KongEarly P1C (39)
Letrozole
Soft Tissue Sarcoma
OHSU Knight Cancer InstituteEarly P1C (39)
Levocarnitine
Drug-Induced Liver Injury
Children's Hospital of Orange CountyEarly P1C (39)
LIDOCAINE
Chronic Non-specific Low Back Pain
National and Kapodistrian University of AthensEarly P1C (39)
LIDOCAINE
Facelift Surgery
University of MinnesotaEarly P1C (39)
LIDOCAINE
Hemorrhage
University of MinnesotaEarly P1C (39)
LIDOCAINE
Opioid-Refractory Chronic Cancer-Related Pain
National and Kapodistrian University of AthensEarly P1C (39)
Liraglutide
Acute Leukemia
University of ChicagoEarly P1C (39)
Liraglutide
Craniopharyngioma
Seoul National University HospitalEarly P1C (39)
Liraglutide
Acquired Hypothalamic Obesity
Seoul National University HospitalEarly P1C (39)
Liraglutide
Long COVID-19
University of ChicagoEarly P1C (39)
Liraglutide
Panhypopituitarism
Seoul National University HospitalEarly P1C (39)
Lisinopril
Radiation Injury
University of RochesterEarly P1C (39)
Lisinopril
Urinary System Disorder
University of RochesterEarly P1C (39)
Lorlatinib
Diffuse Midline Glioma, H3 K27-Altered
Nationwide Children's HospitalEarly P1C (39)
Lorlatinib
Infant-Type Hemispheric Glioma
Nationwide Children's HospitalEarly P1C (39)
Lorlatinib
Grade III Glioma
Nationwide Children's HospitalEarly P1C (39)
Low THC
Agitation,Psychomotor
Mclean HospitalEarly P1C (39)
Lsd
Lysosomal Storage Disease
University of ChicagoEarly P1C (39)
Lucar-E9D Or Lucar-E9K Cells Product
B-Cell Non-Hodgkin Lymphoma
Beijing GoBroad HospitalEarly P1C (39)
lv009
Adult Acute Lymphoblastic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Early P1C (39)
Showing 601 to 625 of 1,553 assets
PreviousPage 25 of 63Next